Loading...
Laboratoire contributeur dans les Graduate Schools
Derniers dépôts
-
Emeric Boisteau, Laetitia Dahan, Nicolas Williet, Karine Le Malicot, Jérôme Desramé, et al.. Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer. Oncologist, 2024, pp.oyae079. ⟨10.1093/oncolo/oyae079⟩. ⟨hal-04576050⟩